Search

Your selection

Clear all

Filter by content type

Filter by content year

News

Vaxart Highlights Progress of COVID-19, Norovirus and Influenza Programs

January 14, 2025 - … proceed with Phase 1 study following scientific advisory board and FDA feedback; Trial to initiate the first half of … Developments An independent Data and Safety Monitoring Board (DSMB) recommended the continuation of the Phase 2b … proceed with Phase 1 study following scientific advisory board and FDA feedback; Trial to initiate the … Vaxart …
News

Vaxart Provides Business Update and Reports Full Year 2024 Financial Results

March 20, 2025 - … In January 2025 , an independent Data Safety Monitoring Board (DSMB) recommended the study to proceed without … January 2025 , Vaxart appointed Kevin Finney to Vaxart’s Board of Directors. Mr. Finney is a seasoned healthcare executive and experienced board member who brings decades of industry leadership …
News

Vaxart Announces Withdrawal of Reverse Stock Split Proposal

September 19, 2025 - … long-term value for all our stockholders.” Vaxart’s Board and management team thanks its stockholders for their … long-term value for all our stockholders.” Vaxart’s Board and management team thanks its stockholders for their … long-term value for all our stockholders.” Vaxart’s Board and management team thanks its stockholders for their …
News

Vaxart Announces Preliminary Results of Annual Meeting of Stockholders

June 13, 2025 - … in favor of the following proposals in alignment with the Board of Directors’ recommendations: Election of six director … in favor of the following proposals in alignment with the Board of Directors’ recommendations: Election of six director … in favor of the following proposals in alignment with the Board of Directors’ recommendations: Election of six director …
News

Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial

January 13, 2025 - … 13, 2025 General Independent Data Safety Monitoring Board (DSMB) recommends study to proceed without … Source: Vaxart, Inc. Independent Data Safety Monitoring Board (DSMB) recommends study to proceed without … 13, 2025 General Independent Data Safety Monitoring Board (DSMB) recommends study to proceed without …
News

Vaxart’s Founder and Chief Scientific Officer Provides Video Update to Stockholders

May 29, 2025 - … stockholders to vote FOR Proposal No. 2, which grants the Board of Directors authority to implement a reverse split … stockholders to vote FOR Proposal No. 2, which grants the Board of Directors authority to implement a reverse split … stockholders to vote FOR Proposal No. 2, which grants the Board of Directors authority to implement a reverse split …
News

Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate

April 30, 2025 - … challenge. An independent Data and Safety Monitoring Board (DSMB) conducted a pre-planned interim safety data … challenge. An independent Data and Safety Monitoring Board (DSMB) conducted a pre-planned interim safety data … challenge. An independent Data and Safety Monitoring Board (DSMB) conducted a pre-planned interim safety data …
News

Vaxart Submits Proxy Statement for Reverse Stock Split to Support Resumption of Trading on Nasdaq

July 24, 2025 - … Nasdaq Hearings Panel to be held on August 14, 2025 . “The Board of Directors has carefully considered the best … Nasdaq Hearings Panel to be held on August 14, 2025 . “The Board of Directors has carefully considered the best … Nasdaq Hearings Panel to be held on August 14, 2025 . “The Board of Directors has carefully considered the best …
News

Vaxart Announces Adjournment of Annual Meeting of Stockholders

May 21, 2025 - … a proxy or otherwise voted need not take any action. The Board of Directors of Vaxart believes that the approval of … a proxy or otherwise voted need not take any action. The Board of Directors of Vaxart believes that the approval of … a proxy or otherwise voted need not take any action. The Board of Directors of Vaxart believes that the approval of …
News

Vaxart Initiates Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial

May 27, 2025 - … 400 participants by an independent Data Safety Monitoring Board (DSMB). As announced previously, the DSMB recommended … 400 participants by an independent Data Safety Monitoring Board (DSMB). As announced previously, the DSMB recommended … 400 participants by an independent Data Safety Monitoring Board (DSMB). As announced previously, the DSMB recommended …
Scroll to Top